Skip to NavigationSkip to content

News

A patent dispute between Indian pharmaceutical firm Cadila Healthcare and US-based Supernus Pharmaceuticals has been ended with legal calls for a...
Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open...
Bernie Sanders is yet again leading the charge against US pharma as Vermont senators have rallied against advertising and marketing campaigns which...
The FDA has approved Noctiva, administered as a nasal spray, for the treatment of people suffering from nocturnal polyuria – going to the toilet too...
Eli Lilly has revealed strong results in a study comparing its psoriasis treatment, Taltz (ixekizumab), to Johnson & Johnson’s Stelara. The study...
Cipla has halted production of its child-friendly antiretroviral HIV treatment Lopinavir due to the failure by the Government’s Health Ministry to...
The UK High Court has ruled that two of AbbVie patents, related to dosing regimens for rheumatoid arthritis, psoriasis and psoriatic, were invalid....
Phase 3 data for the human monoclonal antibody guselkumab in the treatment of adults with moderate to severe plaque psoriasis, showed significant...
Otsuka Pharmaceuticals, a pharmaceutical firm with headquarters in Japan, has agreed to pay a potential $250 million in a deal for Neurovance; the...
Aranca discusses the considerable advances that have occured in the last few years in gene therapy.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches